Literature DB >> 23339009

Hypercalcaemic crisis due to primary hyperparathyroidism - a systematic literature review and case report.

Angela Gurrado1, Giuseppe Piccinni, Germana Lissidini, Pasquale Di Fronzo, Francesco Vittore, Mario Testini.   

Abstract

Hypercalcaemic crisis is an uncommon and potentially life-threatening manifestation of primary hyperparathyroidism, and it is associated with rapid deterioration of the central nervous system, and cardiac, gastrointestinal, and renal function. We present the case of a 76 year-old man in a sudden coma due to hypercalcaemic crisis as a first manifestation of primary hyperparathyroidism. At first, the patient was treated conservatively, his mental status gradually improved in the next three days. On the ninth day after the initiation of therapy, a minimally invasive radio-guided parathyroidectomy was performed. Histologically, the tumour consisted of densely arranged chief cells immunohistochemically positive for PTH antigens, suggesting adenoma. Calcaemia level and PTH were normalised in the immediate postoperative period. A systematic review was performed by consulting PubMed MEDLINE for publications from 1958 to 2011. This review found a total of 499 reported cases of hypercalcaemic crisis due to primary hyperparathyroidism. Manifestations are neurological alterations, and cardiac, renal and gastrointestinal dysfunctions associated with markedly elevated serum calcium and parathyroid hormone levels. The most frequent histology is the parathyroid adenoma. In untreated cases, mortality is 100%. Despite advances in its management, the mortality rate is still 93.5% in patients treated only conservatively. Medical therapy followed by expeditious parathyroidectomy should be considered as the treatment of choice for patients affected by hypercalcaemic crisis due to a primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23339009

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  8 in total

1.  [Polydipsia, increasing fatigue and a huge mediastinal tumor in a 49-year-old woman].

Authors:  T Friedrich; C Rust; G Bischoff; J G Wechsler; T Jakobs; N Woehrle; F Brettner; H Winter; M Angele; B Wendl
Journal:  Internist (Berl)       Date:  2013-11       Impact factor: 0.743

Review 2.  Primary hyperparathyroidism.

Authors:  Tarıq Madkhali; Amal Alhefdhi; Herbert Chen; Dawn Elfenbein
Journal:  Ulus Cerrahi Derg       Date:  2016-03-01

3.  Oxyphil Cell Parathyroid Adenomas Causing Primary Hyperparathyroidism: a Clinico-Pathological Correlation.

Authors:  Pamela Howson; Schelto Kruijff; Ahmad Aniss; Thomas Pennington; Anthony J Gill; Tristan Dodds; Leigh W Delbridge; Stan B Sidhu; Mark S Sywak
Journal:  Endocr Pathol       Date:  2015-09       Impact factor: 3.943

4.  An unusual cause of hypercalcemic crisis: Water-clear cell double parathyroid adenoma.

Authors:  Fatih Mehmet Yazar; Mustafa Karaağaç; Ali İşler; Ertan Bülbüloğlu; Fikret Ezberci
Journal:  Turk J Surg       Date:  2017-12-01

5.  An Interesting Case of Life-Threatening Hypercalcemia Secondary to Atypical Parathyroid Adenoma versus Parathyroid Carcinoma.

Authors:  Ankur Mishra; David Newman
Journal:  Case Rep Med       Date:  2014-05-13

6.  Surgical management of a giant parathyroid adenoma through minimal invasive parathyroidectomy. A case report.

Authors:  Georgios Sahsamanis; Konstantinos Gkouzis; Stavros Samaras; Dionysios Pinialidis; Georgios Dimitrakopoulos
Journal:  Int J Surg Case Rep       Date:  2017-01-31

Review 7.  A Rare Case of Primary Hyperparathyroidism Caused by a Giant Solitary Parathyroid Adenoma.

Authors:  Ioannis Mantzoros; Despoina Kyriakidou; Konstantinos Galanos-Demiris; Christos Chatzakis; Styliani Parpoudi; Nikolaos Sapidis; Lydia Loutzidou; Orestis Ioannidis; Stamatis Angelopoulos; Konstantinos G Tsalis
Journal:  Am J Case Rep       Date:  2018-11-08

8.  A rare case report of multiple myeloma presenting with paralytic ileus and type II respiratory failure due to hypercalcemic crisis.

Authors:  Yuchen Guo; Liang He; Yiming Liu; Xueyuan Cao
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.